Pharmacokinetics, tissue distribution, metabolism, and excretion of depside salts from Salvia miltiorrhiza in rats

被引:55
作者
Li, Xiaochuan
Yu, Chen
Lu, Youli
Gu, Yunlong
Lu, Jie
Xu, Wei
Xuan, Lijiang
Wang, Yiping [1 ]
机构
[1] Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
关键词
D O I
10.1124/dmd.106.013045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salviae miltiorrhiza, a traditional Chinese medical herb known as "Danshen," has been widely used in clinics to improve blood circulation, relieve blood stasis, and treat coronary heart disease. Depside salts from S. miltiorrhiza are a novel drug in which magnesium lithospermate B and its analogs are the active components. The pharmacokinetics, tissue distribution, metabolism, and excretion of three of the major components, lithospermic acid B, rosmarinic acid ( RA), and lithospermic acid ( LA), were studied by liquid chromatography-tandem mass spectrometry following intravenous administration in Sprague-Dawley rats. The elimination half-lives for LSB, RA, and LA were 1.04, 0.75, and 2.0 h, respectively, when 60 mg/kg S. miltiorrhiza depside salts were administrated. The areas under the curve for LSB, RA, and LA were 51.6, 6.6, and 25.2 mg center dot h/l, respectively, and the values decreased in the individual tissues in the following order: kidney > lung > liver > heart > spleen > brain for LSB; kidney > lung > heart > liver > spleen > brain for RA; and heart > lung > kidney > liver > spleen > brain for LA. After intravenous administration of 60 mg/kg S. miltiorrhiza depside salts, 86% of the LSB was excreted in the bile within 6 h. The main metabolites M1 and M2 were found in the serum. Overall, the results show that depside salts from S. miltiorrhiza are rapidly and widely distributed to tissues after intravenous administration in rats but that they are also rapidly cleared and excreted.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 20 条
[11]  
PARNHAM M J, 1985, Drugs of the Future, V10, P756
[12]  
Wu XJ, 2000, ACTA PHARMACOL SIN, V21, P855
[13]   Magnesium lithospermate B ameliorates cephaloridine-induced renal injury [J].
Yokozawa, T ;
Dong, EB ;
Liu, ZW ;
Shibata, T ;
Hasegawa, M ;
Watanabe, H ;
Oura, H .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1997, 49 (05) :337-341
[14]  
YOKOZAWA T, 1989, CHEM PHARM BULL, V37, P2766, DOI 10.1248/cpb.37.2766
[15]   AUGMENTATION OF RENAL RESPONSE BY MAGNESIUM LITHOSPERMATE-B [J].
YOKOZAWA, T ;
OURA, H ;
LEE, TW ;
NONAKA, G ;
NISHIOKA, I .
NEPHRON, 1991, 57 (01) :78-83
[16]   EFFECT OF MAGNESIUM LITHOSPERMATE-B IN RATS WITH SODIUM-INDUCED HYPERTENSION AND RENAL-FAILURE [J].
YOKOZAWA, T ;
LEE, TW ;
OURA, H ;
NONAKA, G ;
NISHIOKA, I .
NEPHRON, 1992, 60 (04) :460-465
[17]   CONFIRMATION THAT MAGNESIUM LITHOSPERMATE-B HAS A HYDROXYL RADICAL-SCAVENGING ACTION [J].
YOKOZAWA, T ;
CHUNG, HY ;
DONG, E ;
OURA, H .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1995, 47 (05) :341-344
[18]   Magnesium lithospermate B is excreted rapidly into rat bile mostly as methylated metabolites, which are potent antioxidants [J].
Zhang, Y ;
Akao, T ;
Nakamura, N ;
Hattori, M ;
Yang, XW ;
Duan, CL ;
Liu, JX .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (07) :752-757
[19]   Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat [J].
Zhang, Y ;
Akao, T ;
Nakamura, N ;
Duan, CL ;
Hattori, M ;
Yang, XW ;
Li, JX .
PLANTA MEDICA, 2004, 70 (02) :138-142
[20]  
Zhou CX, 1999, J CHIN PHARM U, V30, P411